Dr Deena Solomon, MD | |
354 Waverley St, Framingham, MA 01702-7079 | |
(508) 270-5700 | |
(508) 370-3637 |
Full Name | Dr Deena Solomon |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 354 Waverley St, Framingham, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730164328 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD60410099 (Washington) | Secondary |
208000000X | Pediatrics | 275381 (Massachusetts) | Primary |
Entity Name | Edward M Kennedy Community Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609842152 PECOS PAC ID: 3476512740 Enrollment ID: O20041004000840 |
News Archive
Individuals have their own inherent biases. Most are harmless – preferred foods, favorite cars, go-to streaming services. However, biases tied to race, gender, sexual orientation and socioeconomic status have serious consequences.
Heart disease is the number one killer in the United States, and high triglyceride levels in the blood are cited as just one of several risk factors. Millions of lipid panels, blood tests that look at cholesterol levels as well as triglycerides, are performed in clinics each year.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Deena Solomon, MD 650 Lincoln St, Worcester, MA 01605-2060 Ph: (508) 854-2122 | Dr Deena Solomon, MD 354 Waverley St, Framingham, MA 01702-7079 Ph: (508) 270-5700 |
News Archive
Individuals have their own inherent biases. Most are harmless – preferred foods, favorite cars, go-to streaming services. However, biases tied to race, gender, sexual orientation and socioeconomic status have serious consequences.
Heart disease is the number one killer in the United States, and high triglyceride levels in the blood are cited as just one of several risk factors. Millions of lipid panels, blood tests that look at cholesterol levels as well as triglycerides, are performed in clinics each year.
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
› Verified 5 days ago
Dr. Stacey Dawn Maslow, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-872-1260 | |
Dr. Katherine Harer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 Fax: 508-383-1654 | |
Dr. Gertrude M Moffat, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 33 Edgell Rd, Framingham, MA 01701 Phone: 508-620-6615 Fax: 508-879-1597 | |
Dr. Charles G Murphy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Dept Of Emergency Medicine, Framingham, MA 01702 Phone: 508-383-1104 | |
Courtney Mcguire, Pediatrics Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1559 | |
Jennifer Eve Novick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8 Lyman Way, Framingham, MA 01701 Phone: 508-877-4141 | |
Dr. Jerry Wortzman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 |